Tourbillon Capital Partners, L.P. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 103 filers reported holding IMMUNOMEDICS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tourbillon Capital Partners, L.P. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2016$14,313,000
+12.9%
3,900,0000.0%0.28%
+6.6%
Q3 2016$12,676,000
+40.1%
3,900,0000.0%0.26%
+42.5%
Q2 2016$9,048,0003,900,0000.18%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
RP Management, LLC 4,373,178$371,851,00055.73%
Avoro Capital Advisors LLC 26,250,000$2,232,038,00031.71%
Twin Securities, Inc. 467,761$39,774,00028.60%
Palo Alto Investors LP 4,852,383$412,598,00022.65%
Sand Grove Capital Management LLP 470,000$39,964,00021.19%
Beryl Capital Management LLC 1,046,632$88,995,00016.02%
Western Standard LLC 158,065$13,440,00015.26%
One68 Global Capital, LLC 60,990$5,186,00013.76%
First Light Asset Management, LLC 1,577,880$134,167,00013.75%
Boxer Capital, LLC 4,500,000$382,635,00013.22%
View complete list of IMMUNOMEDICS INC shareholders